NCT01028690 - Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

January 31, 2012

Conditions

Helicobacter Pylori InfectionDyspepsia

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri

Lactobacillus reuteri is a mixture of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475; will be delivered at a dose of 1x108 CFU of each strain. One dose is to be taken once per day giving a dose of L. reuteri of 2x108 CFU/day. Will be taken daily throughout the entire study, from the day of inclusion to the final analysis at the end of follow-up after eradication therapy. Will be delivered either in a chewable tablet form

DIETARY_SUPPLEMENT

Placebo

placebo

Trial Locations (1)

64460

Centro Regional para el Estudio de las Enfermedades Digestivas, Facultad de Medicina y Hospital Universitario, UANL, Monterrey